• Reduce text

    Reduce text
  • Restore text size

    Restore text size
  • Increase the text

    Increase the text
  • Print

    Print

Creation of an International Associated Laboratory between the Joint Research Unit STLO and a Brazilian university

The result of several years of collaboration between the Joint Research Unit for the Science and Technology of Milk and Eggs (STLO) and scientists at the Federal University of Minas Gerais in Belo Horizonte, Brazil, this International Associated Laboratory is the first for INRA with a South American country. It is also the first International Associated Laboratory to be managed by an INRA team in Bretagne-Normandie.

French & Brazilian flags
By Service communication Inra Bretagne-Normandie
Updated on 04/25/2018
Published on 03/20/2018

Scientists in the Joint Research Unit for the Science and Technology of Milk and Eggs (STLO) have long maintained fruitful collaborations with teams in Brazil. Microbiologists in particular have been making regular exchanges since 2000 with researchers from the Federal University of Minas Gerais (UFMG) in Belo Horizonte. These exchanges, involving teams from STLO and MICALIS (INRA Jouy-en-Josas), have now been accredited by INRA and UFMG in the context of this new International Associated Laboratory. A five-year agreement has been signed between the two partners and is likely to be renewed once.

Developing new therapeutic strategies to control inflammatory diseases

The International Associated Laboratory has determined a framework for the Bact-Inflam research project which associates INRA scientists with three teams from UFMG specialised in bioinformatics and immunology. Bact-Inflam aims to obtain a clearer understanding of the involvement of bacteria in the pro- or anti-inflammatory processes associated with chronic inflammatory bowel diseases (CIBD) and mastitis; two major diseases that affect humans and animals, respectively.

The Bact-Inflam project thus aims to develop new therapeutic strategies and alternatives to allopathic treatments. Indeed, beneficial bacteria – such as certain lactic acid or propionic bacteria or commensal bacteria in the gut – display activities that could be used to prevent CIBD or mastitis, or as supplements or alternatives to the treatments (including antibiotics) used for these diseases.

The French part of the IAL is being coordinated by Yves Le Loir, Director of STLO and instigator of this International Associated Laboratory, and Jean-Marc Chatel from MICALIS. The kick-off meeting for the Bact-Inflam project will take place in May, in Belo Horizonte.